Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Nov;24(5):764–770. doi: 10.1128/aac.24.5.764

Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.

B F Woolfrey, J M Fox, C O Quall, R T Lally
PMCID: PMC185939  PMID: 6419674

Abstract

Two hundred fifteen Pseudomonas aeruginosa isolates were tested in parallel by the disk agar diffusion test, using a standardized agar preparation, and by a microbroth test, using dilutions differing by small arithmetic increments. For gentamicin, recently proposed breakpoints of resistance (R) less than or equal to 12 mm and susceptibility (S) greater than or equal to 16 mm produced error rates of 20 and 6.8%, respectively. Limiting the error rate for susceptible interpretations to less than or equal to 2% produced a widening of the intermediate zone to include 67.4% of the isolates tested. For tobramycin, the recently proposed breakpoints of R less than or equal to 12 mm and S greater than or equal to 15 mm were associated with error rates of 66.7 and 1.4%, respectively. Breakpoints of R less than or equal to 12 mm and S greater than or equal to 13 mm were demonstrated to be equally effective when the error rate for susceptible interpretations was limited to less than or equal to 2% by error rate-bound analysis. For amikacin, proposed breakpoints of R less than or equal to 14 mm and S greater than or equal to 17 mm were associated with error rates of 27.3 and 3.2%, respectively. Limiting the error rates for susceptible interpretations to less than or equal to 2% required breakpoints of R less than or equal to 14 mm and S greater than or equal to 18 mm. The ability to establish effective susceptibility breakpoints for tobramycin and amikacin appeared not to be related to the disk agar diffusion test process itself but rather to the high degree of susceptibility of the P. aeruginosa population. These findings severely limit the usefulness of the disk agar diffusion procedure for testing P. aeruginosa versus the aminoglycosides. For this purpose, we recommend dilution tests which employ small arithmetic increment schemes.

Full text

PDF
764

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Effinger L. J. Performances of Mueller-Hinton agars prepared by three manufacturers. Am J Clin Pathol. 1974 Jul;62(1):113–117. doi: 10.1093/ajcp/62.1.113. [DOI] [PubMed] [Google Scholar]
  2. Barry A. L., Thornsberry C., Jones R. N. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories. J Clin Microbiol. 1981 May;13(5):1000–1003. doi: 10.1128/jcm.13.5.1000-1003.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barry A. L., Thornsberry C., Jones R. N., Gerlach E. H. Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation. Am J Clin Pathol. 1981 Apr;75(4):524–531. doi: 10.1093/ajcp/75.4.524. [DOI] [PubMed] [Google Scholar]
  4. Casillas E., Kenny M. A., Minshew B. H., Schoenknecht F. D. Effect of ionized calcium and soluble magnesium on the predictability of the performance of Mueller-Hinton agar susceptibility testing of Pseudomonas aeruginosa with gentamicin. Antimicrob Agents Chemother. 1981 Jun;19(6):987–992. doi: 10.1128/aac.19.6.987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garrod L. P., Waterworth P. M. Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin. J Clin Pathol. 1969 Sep;22(5):534–538. doi: 10.1136/jcp.22.5.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hameister W., Wahlig H. Der Einfluss von Mg - und Ca -Ionen auf die Wirksamkeit von Gentamycin gegen Pseudomonas aeruginosa im Agardiffusionstest. Arzneimittelforschung. 1971 Nov;21(11):1658–1660. [PubMed] [Google Scholar]
  7. Kenny M. A., Pollock H. M., Minshew B. H., Casillas E., Schoenknecht F. D. Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin. Antimicrob Agents Chemother. 1980 Jan;17(1):55–62. doi: 10.1128/aac.17.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Krasemann C., Hildenbrand G. Interpretation of agar diffusion tests. J Antimicrob Chemother. 1980 Mar;6(2):181–187. doi: 10.1093/jac/6.2.181. [DOI] [PubMed] [Google Scholar]
  9. Metzler C. M., DeHaan R. M. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J Infect Dis. 1974 Dec;130(6):588–594. doi: 10.1093/infdis/130.6.588. [DOI] [PubMed] [Google Scholar]
  10. Minshew B. H., Pollock H. M., Schoenknecht F. D., Sherris J. C. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards. Antimicrob Agents Chemother. 1977 Dec;12(6):688–696. doi: 10.1128/aac.12.6.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pollock H. M., Minshew B. H., Kenny M. A., Schoenknecht F. D. Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1978 Sep;14(3):360–367. doi: 10.1128/aac.14.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reller L. B., Schoenknecht F. D., Kenny M. A., Sherris J. C. Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis. 1974 Nov;130(5):454–463. doi: 10.1093/infdis/130.5.454. [DOI] [PubMed] [Google Scholar]
  13. Washington J. A., 2nd, Snyder R. J., Kohner P. C., Wiltse C. G., Ilstrup D. M., McCall J. T. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis. 1978 Feb;137(2):103–111. doi: 10.1093/infdis/137.2.103. [DOI] [PubMed] [Google Scholar]
  14. Woolfrey B. F., Fox J. M., Lally R. T., Quall C. O. Broth microdilution testing of Pseudomonas aeruginosa and aminoglycosides: need for employing dilutions differing by small arithmetic increments. J Clin Microbiol. 1982 Oct;16(4):663–667. doi: 10.1128/jcm.16.4.663-667.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Woolfrey B. F., Fox J. M., Quall C. O. An analysis of error rates for disc agar-diffusion testing of Pseudomonas aeruginosa versus aminoglycosides. Am J Clin Pathol. 1981 Apr;75(4):559–564. doi: 10.1093/ajcp/75.4.559. [DOI] [PubMed] [Google Scholar]
  16. Woolfrey B. F., Fox J. M., Quall C. O. Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa. Am J Clin Pathol. 1981 Jan;75(1):39–44. doi: 10.1093/ajcp/75.1.39. [DOI] [PubMed] [Google Scholar]
  17. Woolfrey B. F., Lally R. T., Quall C. O. Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin. J Clin Microbiol. 1983 Feb;17(2):312–316. doi: 10.1128/jcm.17.2.312-316.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Woolfrey B. F., Quall C. O., Fox J. M. Inability of the API-20E system to speciate the fluorescent group of pseudomonads. Am J Clin Pathol. 1981 Feb;75(2):211–213. doi: 10.1093/ajcp/75.2.211. [DOI] [PubMed] [Google Scholar]
  19. Woolfrey B. F., Ramadei W. A., Quall C. O. Evaluation of the moving intermediate zone concept for determing susceptibility of pseudomonads to gentamicin by the standardized disk agar-diffusion test. Am J Clin Pathol. 1979 Nov;72(5):861–863. doi: 10.1093/ajcp/72.5.861. [DOI] [PubMed] [Google Scholar]
  20. Woolfrey B. F., Ramadei W. A., Quall C. O. Inability of the standardized disk agar-diffusion test to measure susceptibility of the fluorescent group of pseudomonads to gentamicin. Am J Clin Pathol. 1978 Sep;70(3):337–342. doi: 10.1093/ajcp/70.3.337. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES